Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study
Since the declaration of Coronavirus-2019 (COVID-19) as a pandemic by the World Health Organization (WHO), it was clear that vaccination is the best way to overcome it. Sinopharm, AstraZeneca and Pfizer were the first vaccines introduced to defeat it. To recognize the short-term adverse effects amon...
Main Authors: | Heba M. Attash, Luma M. Al-Obaidy, Harith Kh. Al-Qazaz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/2/186 |
Similar Items
-
Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study
by: Muhammad Nauman Zahid
Published: (2021-11-01) -
Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients
by: Abdel-Ellah Al-Shudifat, et al.
Published: (2023-08-01) -
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
by: Suhaila A. Al-Sheboul, et al.
Published: (2022-12-01) -
A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
by: Marian S. Boshra, et al.
Published: (2022-02-01) -
Adverse effects following COVID-19 vaccination in Iran
by: Ebrahim Babaee, et al.
Published: (2022-05-01)